Licensing Opportunity: Universal Influenza Vaccine

 Licensing Opportunity:

Universal Influenza Vaccine

3-D illustration of a flu virus. Credit: NIAID

A universal influenza vaccine was designed by researchers at NIAID’s Vaccine Research Center. The researchers fused an engineered group 2 influenza hemagglutinin (HA) protein with a ferritin subunit. The fusion protein can self-assemble into nanoparticles that display group 2 HA stem domain trimers on their surface. These immunogens can be used in combination with group 1 HA stem-ferritin immunogens as a universal influenza vaccine.

Read more about this exciting licensing opportunity: https://www.ott.nih.gov/technology/e-228-2016-0. 

Follow NIAID Tech Transfer on LinkedIn